146 related articles for article (PubMed ID: 9236259)
1. Reduced bone mass and fat-free mass in women with multiple sclerosis: effects of ambulatory status and glucocorticoid Use.
Formica CA; Cosman F; Nieves J; Herbert J; Lindsay R
Calcif Tissue Int; 1997 Aug; 61(2):129-33. PubMed ID: 9236259
[TBL] [Abstract][Full Text] [Related]
2. Body Composition in Multiple Sclerosis Patients and Its Relationship to the Disability Level, Disease Duration and Glucocorticoid Therapy.
Matusik E; Durmala J; Ksciuk B; Matusik P
Nutrients; 2022 Oct; 14(20):. PubMed ID: 36296931
[TBL] [Abstract][Full Text] [Related]
3. Bone health in ambulatory individuals with multiple sclerosis: impact of physical activity, glucocorticoid use, and body composition.
Mojtahedi MC; Snook EM; Motl RW; Evans EM
J Rehabil Res Dev; 2008; 45(6):851-61. PubMed ID: 19009471
[TBL] [Abstract][Full Text] [Related]
4. Body composition in ambulatory women with multiple sclerosis.
Lambert CP; Lee Archer R; Evans WJ
Arch Phys Med Rehabil; 2002 Nov; 83(11):1559-61. PubMed ID: 12422325
[TBL] [Abstract][Full Text] [Related]
5. Bone mineral density and body composition in men with multiple sclerosis chronically treated with low-dose glucocorticoids.
Zikán V; Týblová M; Raška I; Havrdová E; Luchavová M; Michalská D; Kuběna AA
Physiol Res; 2012; 61(4):405-17. PubMed ID: 22670701
[TBL] [Abstract][Full Text] [Related]
6. Body composition and disability in people with multiple sclerosis: A dual-energy x-ray absorptiometry study.
Pilutti LA; Motl RW
Mult Scler Relat Disord; 2019 Apr; 29():41-47. PubMed ID: 30658263
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D deficiency and reduced bone mineral density in multiple sclerosis: effect of ambulatory status and functional capacity.
Ozgocmen S; Bulut S; Ilhan N; Gulkesen A; Ardicoglu O; Ozkan Y
J Bone Miner Metab; 2005; 23(4):309-13. PubMed ID: 15981027
[TBL] [Abstract][Full Text] [Related]
8. Risk of bone loss in men with multiple sclerosis.
Weinstock-Guttman B; Gallagher E; Baier M; Green L; Feichter J; Patrick K; Miller C; Wrest K; Ramanathan M
Mult Scler; 2004 Apr; 10(2):170-5. PubMed ID: 15124763
[TBL] [Abstract][Full Text] [Related]
9. Mitoxantrone: a review of its use in multiple sclerosis.
Scott LJ; Figgitt DP
CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
[TBL] [Abstract][Full Text] [Related]
10. Skeletal status and body composition in young women with functional hypothalamic amenorrhea.
Podfigurna-Stopa A; Pludowski P; Jaworski M; Lorenc R; Genazzani AR; Meczekalski B
Gynecol Endocrinol; 2012 Apr; 28(4):299-304. PubMed ID: 21957879
[TBL] [Abstract][Full Text] [Related]
11. Functional Mobility and Basic Motor Skills in Patients with Multiple Sclerosis and Its Relation to the Anthropometrical Status and Body Composition Parameters.
Matusik E; Augustak A; Durmala J
Medicina (Kaunas); 2019 Dec; 55(12):. PubMed ID: 31817216
[No Abstract] [Full Text] [Related]
12. Bone loss with multiple sclerosis: effect of glucocorticoid use and functional status.
Dabbaghmanesh MH; Yousefipour GA
Iran Red Crescent Med J; 2011 Jan; 13(1):9-14. PubMed ID: 22946013
[TBL] [Abstract][Full Text] [Related]
13. Body composition in ambulatory patients with multiple sclerosis.
Sioka C; Fotopoulos A; Georgiou A; Papakonstantinou S; Pelidou SH; Kyritsis AP; Kalef-Ezra JA
J Clin Densitom; 2011; 14(4):465-70. PubMed ID: 21835661
[TBL] [Abstract][Full Text] [Related]
14. The relationship of total body bone mineral (TBBMC) to anthropometric variables in postmenopausal women, and contribution of chronological age and years since menopause to TBBMC loss.
Rico H; Revilla M; Hernandez ER; Villa L; Alvarez del Buergo M
Clin Rheumatol; 1993 Dec; 12(4):475-8. PubMed ID: 8124908
[TBL] [Abstract][Full Text] [Related]
15. No association between body composition and walking outcomes in multiple sclerosis.
Jeng B; Motl RW
Mult Scler Relat Disord; 2022 Dec; 68():104242. PubMed ID: 36274282
[TBL] [Abstract][Full Text] [Related]
16. Skeletal and muscular status in juveniles with GFD treated clinical and newly diagnosed atypical celiac disease--preliminary data.
Płudowski P; Karczmarewicz E; Socha J; Matusik H; Syczewska M; Lorenc RS
J Clin Densitom; 2007; 10(1):76-85. PubMed ID: 17289529
[TBL] [Abstract][Full Text] [Related]
17. Changes in bone mineral density and bone metabolism markers in premenopausal women with multiple sclerosis and the relationship to clinical variables.
Terzi T; Terzi M; Tander B; Cantürk F; Onar M
J Clin Neurosci; 2010 Oct; 17(10):1260-4. PubMed ID: 20619660
[TBL] [Abstract][Full Text] [Related]
18. Short-term, high-dose glucocorticoid treatment does not contribute to reduced bone mineral density in patients with multiple sclerosis.
Olsson A; Oturai DB; Sørensen PS; Oturai PS; Oturai AB
Mult Scler; 2015 Oct; 21(12):1557-65. PubMed ID: 25623251
[TBL] [Abstract][Full Text] [Related]
19. Bone metabolism and vitamin D status in patients with multiple sclerosis.
Kępczyńska K; Zajda M; Lewandowski Z; Przedlacki J; Zakrzewska-Pniewska B
Neurol Neurochir Pol; 2016; 50(4):251-7. PubMed ID: 27375138
[TBL] [Abstract][Full Text] [Related]
20. No association between body composition and cognition in ambulatory persons with multiple sclerosis: A brief report.
Sandroff BM; Hubbard EA; Pilutti LA; Motl RW
J Rehabil Res Dev; 2015; 52(3):301-8. PubMed ID: 26230584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
